Maves review

Maves posts $149 for sermorelin’s first month, then $199/month, and $169 for NAD⁺’s first month, then $229/month. It says each product includes a home kit and expedited shipping and carries no membership fee. Its homepage also offers Body Recomp bundles, so the menu is wider than two standalone longevity products. The terms name pharmacy partners GoGoMeds and Red Rock, but do not establish which dispenses a given order. The current About page lists 36 states; a listed state does not guarantee every product or route.

Maves is a telehealth brand operated by Homera Health LLC. Its current offerings include standalone sermorelin and NAD⁺ injections, compounded GLP-1 programs, a Body Recomp bundle pairing a GLP-1 with sermorelin, and Body Recomp + Energy adding NAD⁺. The homepage displays bundle introductory/renewal pairs of $248 then $348/month and $299 then $399/month, respectively; the selected medication, dose and final bill require review. Product pages say insurance is not needed and HSA/FSA cards may be eligible. The brand lists 36 states, with treatment options subject to state and clinician review.

The storefront links each product to assessment and licensed-provider review. Current sermorelin and NAD⁺ pages say a home kit and free expedited shipping are included, with no membership fee; they advertise cancellation at any time but do not promise a refund. The terms identify Homera Health LLC, Beluga Health P.A. and Keeva Medical Group, and list GoGoMeds and Red Rock Pharmacy as partners. They do not assign a pharmacy to each product or patient. A legacy TRT membership section of the terms discusses lab charges and nonrefundable fees, but its applicability to these current products is unclear. Maves lists 36 served states, and prescription sales are final under its returns page.

Current sermorelin pricing is $149 for the first month, then $199/month; NAD⁺ is $169 first month, then $229/month. Both pages say a home kit and free expedited shipping are included and no membership fee applies. They do not establish the dose, supply or whether any patient lab expense is additional. The homepage separately promotes Body Recomp at $248 then $348/month and Body Recomp + Energy at $299 then $399/month. The terms contain membership and lab language whose relevance to these longevity plans is unclear. Budget from the renewal display and confirm the selected first charge, labs and cancellation terms before paying.

Compounded; not FDA-approved. A licensed provider must find treatment appropriate. Maves describes subcutaneous sermorelin and injectable NAD⁺ with home kits, but its current sermorelin page does not show the prior 5 mL (10 mg) vial size. Terms list GoGoMeds and Red Rock Pharmacy as partners without assigning the dispenser for an order. Compounded sterile products are not reviewed by the FDA for purity and potency the way approved drugs are. On the evidence, the two longevity products differ sharply. Sermorelin is a growth-hormone-releasing hormone analog that prompts your own pituitary to release growth hormone, preserving the feedback loop that injected HGH overrides; the mechanism is real and well characterized, and the long-term human outcome data behind the recovery, body-composition and energy claims stays thin. Injected NAD⁺ has no controlled human outcome trials; the oral precursors NR and NMN are the studied forms, and what they demonstrate is a raised blood NAD⁺ level rather than a clinical benefit. Individual results vary.